Keyphrases
Glioblastoma
96%
Oncolytic Herpes Simplex Virus (oHSV)
93%
Oncolytic Virus
86%
Tumor
59%
Glioma
48%
Oncolytic
38%
Brain Tumor
35%
Antitumor Efficacy
33%
Virus
31%
Glioblastoma multiforme
31%
Oncolytic HSV
28%
Virotherapy
28%
Oncolytic Viral Therapy
27%
Natural Killer Cells
27%
Glioblastoma Cells
25%
Tumor Cells
24%
Angiogenesis
22%
Glioma Cells
19%
Tumor Microenvironment
18%
Malignant Glioma
18%
Cancer Cells
15%
MicroRNA
15%
Mouse Model
15%
Macrophages
15%
Herpes Simplex Virus Type 1 (HSV-1)
15%
Clinical Trials
14%
Angiogenesis Inhibitors
14%
Histone Deacetylase Inhibitor (HDACi)
13%
Therapeutic Efficacy
13%
Temozolomide
13%
Brain Angiogenesis
13%
Antitumor Effect
13%
Tumor Growth
13%
Inhibitor-1
12%
Cancer Therapy
12%
Angiogenic
11%
BAI1
11%
Sterol Regulatory Element-binding protein-1c (SREBP-1c)
11%
Endonuclease
11%
Protein Arginine Methyltransferase 5 (PRMT5)
11%
CCN1
11%
Myeloma Cells
11%
Schizosaccharomyces Pombe
10%
Hypoxia
9%
Virus Spread
9%
Anti-angiogenesis
9%
Brain-specific Angiogenesis Inhibitor
9%
Solid Tumors
9%
SiRNA Nanoparticle
9%
Virus Replication
9%
Medicine and Dentistry
Glioblastoma
72%
Neoplasm
71%
Oncolytic Virus
59%
Ganglioglioma
58%
Oncolytic Herpes Virus
56%
Human Alphaherpesvirus 1
29%
Oncolytic Virotherapy
24%
Tumor Cell
22%
Malignant Neoplasm
21%
Virotherapy
20%
In Vitro
18%
Brain Tumor
18%
Infection
15%
Glioma Cell
15%
Xenograft
13%
Tumor Microenvironment
12%
Combination Therapy
12%
Epidermal Growth Factor Receptor
11%
Integrin
11%
Endothelial Cell
11%
Cancer Treatment
11%
Temozolomide
11%
Cancer Therapy
10%
Macrophage
9%
Immunotherapy
9%
Clinical Trial
9%
Cilengitide
9%
Antiangiogenic Activity
8%
Natural Killer Cell
8%
Angiogenesis
8%
Protein Arginine Methyltransferase 5
8%
Cancer Cell
8%
Virus Replication
7%
Immune Response
7%
Tumor Progression
7%
Cytotoxicity
7%
Extracellular Matrix
7%
Virus Infection
7%
N Acetylgalactosamine 4 Sulfatase
7%
Disease
6%
Promoter Region
6%
Tumor Model
6%
Ovarian Cancer
6%
Immunocompetent Cell
6%
Interferon
6%
Trametinib
6%
Antivirus Agent
5%
Herpes Simplex
5%
Histone Deacetylase Inhibitor
5%
Deoxyribonuclease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Glioblastoma
73%
Oncolytic Virus
56%
Malignant Neoplasm
52%
Oncolytic Herpes Virus
47%
Virotherapy
36%
Brain Tumor
32%
Mouse
26%
Human Alphaherpesvirus 1
23%
microRNA
16%
Combination Therapy
12%
Mouse Model
12%
Clinical Trial
11%
Angiogenesis Inhibitor
11%
Epidermal Growth Factor Receptor
11%
Nanoparticle
10%
Tumor Microenvironment
10%
Histone Deacetylase Inhibitor
10%
Infection
9%
Immunotherapy
9%
Antiangiogenic
9%
Cilengitide
9%
Protein Arginine Methyltransferase
8%
Tumor Model
8%
Temozolomide
7%
Cisplatin
7%
Solid Malignant Neoplasm
7%
Integrin
7%
Tumor Growth
7%
Disease
7%
Virus Infection
7%
Antivirus Agent
6%
Tumor Suppressor Protein
6%
Adjuvant
6%
Trametinib
6%
Head and Neck Squamous Cell Carcinoma
5%
Sphingolipid Activator Protein
5%
Breast Cancer
5%
Dioleoylphosphatidylserine
5%
Cetuximab
5%
Multiple Myeloma
5%
Hypoxia
5%
Ovary Cancer
5%